Litcius/Paper detail

Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson’s Disease

Rita Maria Concetta Di Martino, Letizia Pruccoli, Alessandra Bisi, Silvia Gobbi, Angela Rampa, Ana Martı́nez, Concepción Pérez, Loreto Martínez‐González, Maria Paglione, Elia Di Schiavi, Francesca Seghetti, Andrea Tarozzi, Federica Belluti

2020ACS Chemical Neuroscience56 citationsDOIOpen Access PDF

Abstract

emerged as an interesting multitarget derivative, valuable to be exploited in a multitarget PD perspective.

Topics & Concepts

NeuroprotectionCurcuminNeurotoxicityOxidative stressNeuroinflammationPharmacologyParkinson's diseaseAntioxidantInducerChemistryDownregulation and upregulationBiologyNeuroscienceBiochemistryMedicineDiseaseInternal medicineToxicityGeneOrganic chemistryGenomics, phytochemicals, and oxidative stressCurcumin's Biomedical ApplicationsCholinesterase and Neurodegenerative Diseases
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson’s Disease | Litcius